Related Experiment Video
Updated: Jul 28, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months
Christophe Allais1, Christina G Connor1, Nga M Do1
1Pfizer Worldwide Research & Development, Chemical Research & Development, Groton, Connecticut 06355, United States.
Abstract:
The advancement of nirmatrelvir, the active ingredient in Paxlovid, from discovery to emergency use authorization was achieved in just 17 months, requiring an unprecedented rate of chemical process development.
More Related Videos
18:46Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Clinical Trials: Overview
Preclinical Development: Overview